Related Experiment Video
Updated: Apr 18, 2026
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease
Ann Marie Navar-Boggan1, Eric D Peterson2, Ralph B D'Agostino2
1From the Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (A.M.N.-B., E.D.P., B.N., M.J.P.); Boston University, Boston, MA (R.B.D.); and Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Centre, Montreal, Canada (A.D.S.). navar006@mc.duke.edu michael.pencina@duke.edu.
Insights
Prolonged exposure to moderate hyperlipidemia in young adults significantly increases future coronary heart disease (CHD) risk. Current guidelines may overlook individuals who could benefit from early intervention for hypercholesterolemia.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Current cholesterol guidelines for statin therapy primarily focus on 10-year cardiovascular risk.
- Many young adults with moderate hyperlipidemia do not meet these criteria.
- The impact of early-adulthood hypercholesterolemia duration on future coronary heart disease (CHD) risk is not fully understood.
Purpose of the Study:
- To evaluate the association between the duration of hyperlipidemia exposure in early adulthood and the subsequent risk of CHD.
- To determine if cumulative exposure to hypercholesterolemia, even at moderate levels, predicts future cardiovascular events.
Main Methods:
- Analysis of data from the Framingham Offspring Cohort (n=1478) of adults without cardiovascular disease up to age 55.
- Examination of the association between the duration of moderate hyperlipidemia (non-high-density lipoprotein cholesterol ≥ 160 mg/dL) in early adulthood and subsequent CHD incidence.
- Statistical adjustments for other cardiac risk factors were performed.
Main Results:
- CHD rates were significantly elevated with prolonged hyperlipidemia exposure by age 55 (4.4% with no exposure, 8.1% with 1-10 years, 16.5% with 11-20 years; P<0.001).
- This association persisted after adjusting for other risk factors (HR, 1.39 per decade of hyperlipidemia).
- 85% of young adults with prolonged hyperlipidemia did not meet statin criteria at age 40, yet cumulative exposure remained a significant predictor of CHD risk at age 55.
Conclusions:
- Cumulative exposure to hyperlipidemia in young adulthood is dose-dependently associated with increased future CHD risk.
- Adults with prolonged moderate hypercholesterolemia have elevated CHD risk and may benefit from more aggressive primary prevention strategies.
- Long-term hyperlipidemia management in young adults is crucial for mitigating future cardiovascular events.
Background:
Many young adults with moderate hyperlipidemia do not meet statin treatment criteria under the new American Heart Association/American College of Cardiology cholesterol guidelines because they focus on 10-year cardiovascular risk. We evaluated the association between years of exposure to hypercholesterolemia in early adulthood and future coronary heart disease (CHD) risk.
Methods And Results:
We examined Framingham Offspring Cohort data to identify adults without incident cardiovascular disease to 55 years of age (n=1478), and explored the association between duration of moderate hyperlipidemia (non-high-density lipoprotein cholesterol ≥ 160 mg/dL) in early adulthood and subsequent CHD. At median 15-year follow-up, CHD rates were significantly elevated among adults with prolonged hyperlipidemia exposure by 55 years of age: 4.4% for those with no exposure, 8.1% for those with 1 to 10 years of exposure, and 16.5% for those with 11 to 20 years of exposure (P<0.001); this association persisted after adjustment for other cardiac risk factors including non-high-density lipoprotein cholesterol at 55 years of age (hazard ratio, 1.39; 95% confidence interval, 1.05-1.85 per decade of hyperlipidemia). Overall, 85% of young adults with prolonged hyperlipidemia would not have been recommended for statin therapy at 40 years of age under current national guidelines. However, among those not considered statin therapy candidates at 55 years of age, there remained a significant association between cumulative exposure to hyperlipidemia in young adulthood and subsequent CHD risk (adjusted hazard ratio, 1.67; 95% confidence interval, 1.06-2.64).
Conclusions:
Cumulative exposure to hyperlipidemia in young adulthood increases the subsequent risk of CHD in a dose-dependent fashion. Adults with prolonged exposure to even moderate elevations in non-high-density lipoprotein cholesterol have elevated risk for future CHD and may benefit from more aggressive primary prevention.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
01:26Coronary Artery Disease IV: Preventive Measures
01:18Lipids: Dietary Sources and Requirements
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...